BP
PFE icon

BNP Paribas’s Pfizer PFE Stock Holding History

BNP Paribas’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.5M Buy
730,290
+94,316
+15% +$2.51M 0.65% 33
2025
Q4 		$15.8M Buy
635,974
+293,744
+86% +$7.41M 0.45% 43
2025
Q3 		$8.63M Buy
342,230
+23,327
+7% +$576K 0.26% 68
2025
Q2 		$7.73M Sell
318,903
-16,217
-5% -$378K 0.25% 74
2025
Q1 		$8.49M Buy
335,120
+47,541
+17% +$1.24M 0.35% 68
2024
Q4 		$8.42M Buy
287,579
+95,123
+49% +$2.58M 0.05% 60
2024
Q3 		$5.57M Buy
192,456
+4,203
+2% +$123K 0.23% 69
2024
Q2 		$5.27M Sell
188,253
-29,578
-14% -$814K 0.27% 67
2024
Q1 		$6.05M Buy
+217,831
New +$6.04M 0.28% 68

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BNP Paribas's PFE Position: Q1 2026 in Review

BNP Paribas increased its Pfizer (PFE) stake by 15% in Q1 2026, buying an estimated $2.51M and bringing the position to 730,290 shares worth $20.5M. The position accounts for 0.65% of the portfolio, ranked #33.

BNP Paribas first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • BNP Paribas held 730,290 shares of Pfizer worth $20.5M as of Q1 2026.
  • BNP Paribas bought 94,316 Pfizer shares in Q1 2026, an estimated $2.51M.
  • Pfizer made up 0.65% of BNP Paribas's portfolio in Q1 2026, its #33 holding.
  • BNP Paribas first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on BNP Paribas's 13F filing for Q1 2026, filed 12 May 2026.